Amgen to Invest $600 Million in New Science and Innovation Center at Thousand Oaks Headquarters – geneonline.com

Amgen is investing $600 million in a new Science and Innovation Center at its Thousand Oaks, California headquarters. The center will enhance Amgen’s research and development capabilities, fostering collaboration and innovation. The project underscores Amgen’s commitment to Southern California and its dedication to discovering and developing innovative medicines for serious illnesses. This investment will create new jobs and contribute to the region’s economic growth, solidifying Amgen’s position as a leading biotechnology company. The facility is expected to accelerate Amgen’s scientific advancements and contribute to improved patient outcomes.

News summary provided by Gemini AI.